Skip to main content

RP Mason

First name:
RP
Last name:
Mason
Sherratt, S. C. R., & Mason, R. P. (2018). Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid. Biochemical And Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2018.01.062 (Original work published 2018)
Zhou, H., Arias-Ramos, N., López-Larrubia, P., Mason, R. P., Cerdán, S., & Pacheco-Torres, J. Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods In Molecular Biology (Clifton, N.j.), 1718, 297-313. https://doi.org/10.1007/978-1-4939-7531-0_18 (Original work published 2018)
Borow, K. M., Mason, R. P., & Vijayaraghavan, K. (2017). Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review. Cardiorenal Medicine, 8(1), 18-30. https://doi.org/10.1159/000479391
Sherratt, S. C. R., & Mason, R. P. (2018). Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction. Chemistry And Physics Of Lipids. https://doi.org/10.1016/j.chemphyslip.2018.01.002 (Original work published 2018)
Verma, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., et al. (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)